VP3.15 structure
|
Common Name | VP3.15 | ||
---|---|---|---|---|
CAS Number | 1281681-54-6 | Molecular Weight | 366.48 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C20H22N4OS | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of VP3.15VP3.15 is a potent, orally bioavailable and CNS-penetrant dual phosphodiesterase (PDE)7- glycogen synthase kinase (GSK)3 inhibitor, with IC50s of 1.59 μM and 0.88 μM for PDE7 and GSK-3, respectively. VP3.15 has neuroprotective and neuroreparative activities, thus as potential combined anti-inflammatory and pro-remyelinating therapies for multiple sclerosis (MS)[1]. |
Name | VP3.15 |
---|
Description | VP3.15 is a potent, orally bioavailable and CNS-penetrant dual phosphodiesterase (PDE)7- glycogen synthase kinase (GSK)3 inhibitor, with IC50s of 1.59 μM and 0.88 μM for PDE7 and GSK-3, respectively. VP3.15 has neuroprotective and neuroreparative activities, thus as potential combined anti-inflammatory and pro-remyelinating therapies for multiple sclerosis (MS)[1]. |
---|---|
Related Catalog | |
Target |
IC50: 1.59 μM (PDE7), 0.88 μM (GSK-3)[1] |
References |
Molecular Formula | C20H22N4OS |
---|---|
Molecular Weight | 366.48 |